Update on the COVID-19 pandemic

Information regarding COVID-19 is in constant change, as is the situation regarding vaccination and prioritization for immune-compromised individuals.

If you have any COVID-19-related questions, we’ve created a specific COVID section on our website that can be accessed by clicking here or by selecting the “News & Events” tab from our homepage. In this section, you’ll find the latest news and information about the pandemic in Canada from trustworthy and reliable sources.

Any specific questions that you may have regarding the COVID-19 vaccination, delays between vaccine dosing, and prioritization within your province are best answered by your healthcare team. They’re the ones who know you and your particular situation and are therefore in a position to best address your unique concerns.

Created by, and entirely focused on, Canadians impacted by myeloma, Myeloma Canada is the only national charitable organization committed to providing you with the most up-to-date and reliable information on myeloma. Some of the ways we do this is through our monthly e-newsletter, “Myeloma Matters”, as well as through our social media platforms.

Please don’t hesitate to contact us at contact@myeloma.ca or toll-free at 1-888-798-5771 with any questions regarding our programs and services.


Make a donation

Response to Treatment

When reading about multiple myeloma – and more particularly about research – you're likely to come across terms like "complete response" (CR) or "partial response" (PR).

Please be aware that different studies may apply different definitions to the same terms.

Below are the acronyms of the response categories used by the International Myeloma Working Group.

sCR stringent Complete Response
CR Complete Response
VGPR Very Good Partial Response
PR Partial Response
SD Stable Disease
PD Progressive Disease

For a definition of these response categories, please consult page 26 of the Multiple Myeloma Patient Handbook.

The three Rs

Remission is the complete or partial disappearance of the signs and symptoms of myeloma.
Relapse is when signs and symptoms of myeloma return after a period of improvement.
Refractory is the term used to describe myeloma that does not respond to treatment. 

Experiencing a Relapse in Multiple Myeloma

Many patients can live full and productive lives for years after diagnosis, even after experiencing a relapse. Watch the video below and to hear stories from other patients who have experienced a relapse. For more information on treatment options, click here.